Posts by Sandra Ansanay-Alex
Bioproduction Forum
The Bioproduction Forum is taking place on 2-3 June 2026 in Lausanne. The event is co-organized by MabDesign and A3P. This event brings together Europe’s biopharmaceutical community to explore the latest advances shaping the future of bioproduction. Designed as a complementary addition to the long-standing Bioproduction Congress in Lyon, this first edition aims to broaden the…
Read MoreHuman Health by Design – Call For Project
Apply before 31 May 2026 for the H4 Human Health by Design programme, and get a 6-month support and up to CHF 10,000 in non-dilutive funding. Human Health by Design supports early‑stage startups developing medical devices or digital health solutions, combining clinical immersion through H4 | La Source with the design expertise of Enabled by Design (EPFL/ECAL). The programme…
Read MoreThree Life Sciences Companies Finalist of the Strategis Award
The jury of the Prix Strategis selected five companies, to advance to the final round of the competition. Three of them are Swiss Health Valley projects. Irmos Technologies AG, which develops solutions to extend the lifespan of infrastructure. Neology SA, which offers a clean alternative to diesel. Virtuosis AI, specialized in intelligent vocal biomarkers. Isospec…
Read MoreFONGIT Force x Pierre Strübin
The FONGIT Force Event, The Essentials of Startup Leadership and Governance, with Pierre Strübin is taking place on 12 May 2026 at FONGIT HQ in Plan-les-Ouates (Geneva) Strong governance is not bureaucracy — it is a competitive advantage for startup success. In this in-person lunchtime workshop, Pierre Strübin will distill the core leadership and governance…
Read More3 Rs Day
The 3 Rs Day will take place at the Biozentrum in Basel on 11 June 2026, and will focus on advancing the 3Rs in immunology and infectious disease 3Rs Day is the Swiss 3RCC’s flagship annual event, bringing together researchers, animal welfare officers and professionals working with animals in research to exchange knowledge, foster collaboration and discuss…
Read MoreMicronarc Prize x PX Group
Apply before 31 August 2026 for the Micronarc Prize x PX Group and try to get CHF 5,000 and a booth at one of Micronarc’s events This annual award recognizes subcontractors in French-speaking Switzerland active in the field of micro- and nanotechnologies—that is, companies that contribute to their clients’ success through technological, business, or service…
Read MoreVenture Technology Connect
Apply for Venture Technology Connect and go to Verbier next November to pitch you project to a selected audience of investors Swiss start-ups are seeking for capital to fuel their growth. And investors want to invest their money intelligently, according to their values and preferences. Venture Technology Connect is coming to the Verbier region for…
Read MoreMission BioCapital Platinum Programme
Apply before 15 May 2026 for next Mission BioCapital Platinum Programme, designed to help early-stage biotech projects Mission BioCapital (MBC), in partnership with sponsors AbbVie, Ono Venture Investment (OVI), Toronto Innovation Acceleration Partners (TIAP), Connecticut Innovations, Alloy Therapeutics, HitGen, CCRM, Goodwin, Norton Rose Fulbright, and van den Boom & Associates announced today that applications are…
Read MoreEPFL Innogrants
Five EPFL-based startups: Alpion CryoSolutions, Eleum, Feedback Intuitive, MOLECL, and NourishAI are the latest recipients of the EPFL Startup Launchpad Innogrant and Innogrant for biotherapeuthics. Each team has secured CHF 100,000 to accelerate the development of their technology. Alpion CryoSolutions Cryo-electron microscopy has transformed biology by allowing researchers to see proteins in extraordinary detail. However, existing technology only…
Read MoreAC Immune and Eli Lilly Sign New Agreement Worth CHF 10 Million
Eli Lilly has handed Vaud-based AC Immune (Switzerland) 10 million Swiss francs ($12.5 million) to expand their Alzheimer’s disease collaboration as a candidate moves closer to the clinic. The U.S. pharma first tapped up AC Immune in a 2018 deal that included an $81 million upfront fee. That pact, which came with up to 1.7 billion francs ($2.1 billion)…
Read More